Cognitive-Behavior Therapy (CBT) for Panic Disorder: Relationship of Anxiety and Depression Comorbidity with Treatment Outcome

Laura B Allen, Kamila S White, David H Barlow, M Katherine Shear, Jack M Gorman, Scott W Woods, Laura B Allen, Kamila S White, David H Barlow, M Katherine Shear, Jack M Gorman, Scott W Woods

Abstract

Research evaluating the relationship of comorbidity to treatment outcome for panic disorder has produced mixed results. The current study examined the relationship of comorbid depression and anxiety to treatment outcome in a large-scale, multi-site clinical trial for cognitive-behavior therapy (CBT) for panic disorder. Comorbidity was associated with more severe panic disorder symptoms, although comorbid diagnoses were not associated with treatment response. Comorbid generalized anxiety disorder (GAD) and major depressive disorder (MDD) were not associated with differential improvement on a measure of panic disorder severity, although only rates of comorbid GAD were significantly lower at posttreatment. Treatment responders showed greater reductions on measures of anxiety and depressive symptoms. These data suggest that comorbid anxiety and depression are not an impediment to treatment response, and successful treatment of panic disorder is associated with reductions of comorbid anxiety and depressive symptoms. Implications for treatment specificity and conceptual understandings of comorbidity are discussed.

Figures

Fig. 1
Fig. 1
PDSS-IE scores (with standard errors) across treatment for participants with no comorbidity, only anxiety comorbidity, only depression comorbidity, and both anxiety and depression comorbidity. PDSS-IE panic disorder severity scale—independent evaluator version, Pre pretreatment, Post posttreatment

References

    1. Aaronson CJ, Shear MK, Goetz RR, Allen LB, Barlow DH, White KS, et al. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy. Journal of Clinical Psychiatry. 2008;69:418–424. doi: 10.4088/JCP.v69n0312.
    1. Barlow DH, Craske MG. Mastery of your anxiety and panic: Workbook. 4. New York: Oxford University Press; 2007.
    1. Barlow DH, Allen LB, Choate ML. Towards a unified treatment for emotional disorders. Behavior Therapy. 2004;35:205–230. doi: 10.1016/S0005-7894(04)80036-4.
    1. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin. 1946;2:47–53. doi: 10.2307/3002000.
    1. Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. Journal of Consulting and Clinical Psychiatry. 1992;60:835–844. doi: 10.1037/0022-006X.60.6.835.
    1. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment. Journal of Consulting and Clinical Psychiatry. 1995;63:754–765. doi: 10.1037/0022-006X.63.5.754.
    1. Brown TA, Antony MM, Barlow DH. Diagnostic comorbidity in panic disorder: effect on treatment outcome and course of comorbid diagnoses following treatment. Journal of Consulting and Clinical Psychiatry. 1995;63:408–418. doi: 10.1037/0022-006X.63.3.408.
    1. Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. Journal of Abnormal Psychology. 2001a;110:585–599. doi: 10.1037/0021-843X.110.4.585.
    1. Brown TA, Di Nardo PA, Lehman CL, Campbell LA. Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. Journal of Abnormal Psychology. 2001b;110:49–58. doi: 10.1037/0021-843X.110.1.49.
    1. Campbell-Sills L, Barlow DH. Incorporating emotion regulation into conceptualizations and treatments of anxiety and mood disorders. In: Gross JJ, editor. Handbook of emotion regulation. New York: Guilford; 2007. pp. 542–559.
    1. de Ruiter C, Rijken H, Garssen B, van Schaik A, Kraaimaat F. Comorbidity among the anxiety disorders. Journal of Anxiety Disorders. 1989;3:57–68. doi: 10.1016/0887-6185(89)90001-7.
    1. Di Nardo PA, Brown TA, Barlow DH. Anxiety disorders interview schedule for DSM-IV. Albany, NY: Graywind; 1994.
    1. Guy W. ECDEU assessment manual for psychopharmacology, revised (DHEW Publication No. ADM 76-338) Washington, DC: U.S. Government Printing Office; 1976.
    1. Hafner J, Marks IM. Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. Psychological Medicine. 1976;6:71–88. doi: 10.1017/S0033291700007510.
    1. Hamilton M. The assessment of anxiety states by rating. British Journal of Psychiatry. 1959;32:50–55.
    1. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56.
    1. Laberge B, Gauthier JG, Cote G, Plamondon J, Cormier HJ. Cognitive-behavioral therapy of panic disorder with secondary major depression: a preliminary investigation. Journal of Consulting and Clinical Psychiatry. 1993;61:1028–1037. doi: 10.1037/0022-006X.61.6.1028.
    1. Maser JD, Cloninger CR, editors. Comorbidity of mood and anxiety disorders. Washington, DC: American Psychiatric; 1990.
    1. McLean PD, Woody S, Taylor S, Koch WJ. Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy. Journal of Consulting and Clinical Psychiatry. 1998;66:240–247. doi: 10.1037/0022-006X.66.2.240.
    1. Mundt JC, Marks IM, Shear MK, Greist JH. The work and social adjustment scale: a simple measure of impairment in functioning. British Journal of Psychiatry. 2002;180:461–464. doi: 10.1192/bjp.180.5.461.
    1. Peterson RA, Reiss S. Anxiety sensitivity index manual. Worthington, OH: IDS; 1987.
    1. Reif W, Trenkamp S, Auer C, Fichter MM. Cognitive behavioral therapy in panic disorder and comorbid major depression. Psychotherapy and Psychosomatics. 2000;69:70–78. doi: 10.1159/000012369.
    1. Sanderson WC, Di Nardo PA, Rapee RM, Barlow DH. Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal Psychology. 1990;99:308–312. doi: 10.1037/0021-843X.99.3.308.
    1. Shear MK, Brown TA, Sholomskas DE, Barlow DH, Gorman JM, Woods SW, et al. Panic disorder severity scale (PDSS) Pittsburgh, PA: Department of Psychiatry, University of Pittsburgh School of Medicine; 1992.
    1. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. American Journal of Psychiatry. 1997;154:1571–1575.
    1. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, et al. Reliability and validity of a structured interview guide for the Hamilton anxiety rating scale (SIGH-A) Depression and Anxiety. 2001;13:166–178. doi: 10.1002/da.1033.
    1. Steketee G, Chambless DL, Tran GQ. Effects of Axis I and II comorbidity on behavior therapy outcome for obsessive–compulsive disorder and agoraphobia. Comprehensive Psychiatry. 2001;42:76–86. doi: 10.1053/comp.2001.19746.
    1. Tsao JCI, Lewin MR, Craske MG. The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. Journal of Anxiety Disorders. 1998;12:357–371. doi: 10.1016/S0887-6185(98)00020-6.
    1. Tsao JCI, Mystkowski JL, Zucker BG, Craske MG. Effects of cognitive-behavior therapy for panic disorder on comorbid conditions: replication and extension. Behavior Therapy. 2002;33:493–509. doi: 10.1016/S0005-7894(02)80013-2.
    1. Williams JB. A structured interview guide for the Hamilton depression rating scale. Archives of General Psychiatry. 1988;45:742–747.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться